Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Clotrimazole Troche in Oropharyngeal Candidiasis
NCT02635438Phase 3Unknown
- Sponsor
- THINQ Pharma
- Start
- Dec 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clotrimazole in oropharyngeal candidiasis (OPC), sponsored by THINQ Pharma. Status: unknown.
02
Drugs
clotrimazole
03
Conditions
oropharyngeal candidiasis (OPC)
Beyond the preview
Go deeper on NCT02635438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02635438.